ABSTRACT

Testicular germ cell tumors are the most common cause of cancer in men between the age of 15 and 45 years and most patients have stage 1 disease at presentation. Although well defined clinical guidelines are present for the diagnosis and the treatment of testicular carcinoma there is not enough study published on the ideal follow-up of patients with stage 1 testicular carcinoma. An ideal follow-up protocol should not only provide early detection and treatment of recurrences but also ensure identification and reduction of side effects and secondary malignancies due to treatment. Besides, it should be economically feasible. In this article, the current literature and novelties regarding ideal follow-up for stage 1 testicular carcinoma were reviewed.